How vaccine makers are tackling the viral vector bottleneck To view this email as a web page,
click here Johnson & Johnson's COVID-19 vaccine scores longer shelf life just as millions of doses were set to expire OSHA releases new standard to protect front-line health workers from COVID-19 Vexed by vectors: How COVID-19 vaccine and cell and gene players are tackling the viral vector bottleneck COVID-19 tracker: CDC reports higher rate of heart inflammation cases after Pfizer, Moderna jabs Kaiser Permanente is leveraging its wealth of member and community data to craft new vaccine promotion programs Featured Story | By Noah Higgins-Dunn Just as millions of Johnson & Johnson COVID-19 vaccines were set to expire by June's end, the FDA on Thursday said the jabs could be kept on the shelf a month and half longer than originally suggested. read more |
| |
|---|
|
| | Benefits of Decentralized Clinical Trials To execute decentralized research strategies, sponsors are turning to an integrated supply chain solution known as Direct-to-Patient Services. This service allows patients to participate in clinical trials from their homes by providing them with study drugs and care where they live. Learn more. |
Top Stories By Robert King OSHA released a new emergency temporary standard Thursday that outlines requirements for hospitals and other providers to protect their workers from contracting COVID-19. read more By Fraiser Kansteiner To crank out enough viral vectors to meet short-term demand for cell and gene therapies, not to mention some COVID-19 vaccines, the industry would need to have 3 billion to 6 billion liters of bioreactor capacity a year, GlobalData figures. It currently has less than 1% of that. read more By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner The CDC said there's been a higher-than-expected level of heart inflammation cases following a second shot from either Pfizer-BioNTech or Moderna, although a direct link hasn't been established. The FDA awarded Johnson & Johnson's shot a longer shelf life just as millions of doses were set to expire. And more headlines. read more By Dave Muoio The large integrated health system has announced a sweepstakes lottery, community grants and other outreach programs supporting President Joe Biden's Fourth of July vaccination goal. read more | | Webinar: Accelerating NASH Clinical Trials Tuesday, June 15 | 10am ET / 7am PT Join industry leaders for a webinar dedicated to overcoming key challenges presented in NASH drug development. We’ll explore key considerations for liver biopsy collection and interpretation, emerging non-invasive biomarkers, and the connection between clinical practice and drug development. Register now. |
|
|
